REPORT ID 1560

EMEA (Europe, Middle East and Africa) DVT Screening Devices Market Report 2017

Publish Date
06-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the EMEA DVT Screening Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of DVT Screening Devices for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA DVT Screening Devices market competition by top manufacturers/players, with DVT Screening Devices sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    F. Hoffmann-La Roche Ltd.
    Generex Biotechnology Lorporation
    Laboratorios Farmaceuticos Rovi, S.A.
    Pharmathen Pharmaceuticals S.A.
    Bristol-Myers Squibb Company
    3SBio Inc.
    Dupont Pharm Co
    Wockhardt Ltd
    Bayer AG
    Pfizer Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Imaging Modalities
    Intravasular Ultrasound
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Research Centre
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) DVT Screening Devices Market Report 2017
1 DVT Screening Devices Overview
    1.1 Product Overview and Scope of DVT Screening Devices
    1.2 Classification of DVT Screening Devices
        1.2.1 EMEA DVT Screening Devices Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA DVT Screening Devices Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Imaging Modalities
        1.2.4 Intravasular Ultrasound
        1.2.5 Others
    1.3 EMEA DVT Screening Devices Market by Application/End Users
        1.3.1 EMEA DVT Screening Devices Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Research Centre
        1.3.5 Others
    1.4 EMEA DVT Screening Devices Market by Region
        1.4.1 EMEA DVT Screening Devices Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of DVT Screening Devices (2012-2022)
        1.5.1 EMEA DVT Screening Devices Sales and Growth Rate (2012-2022)
        1.5.2 EMEA DVT Screening Devices Revenue and Growth Rate (2012-2022)

2 EMEA DVT Screening Devices Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA DVT Screening Devices Market Competition by Players/Manufacturers
        2.1.1 EMEA DVT Screening Devices Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA DVT Screening Devices Revenue and Share by Players (2012-2017)
        2.1.3 EMEA DVT Screening Devices Sale Price by Players (2012-2017)
    2.2 EMEA DVT Screening Devices (Volume and Value) by Type/Product Category
        2.2.1 EMEA DVT Screening Devices Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA DVT Screening Devices Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA DVT Screening Devices Sale Price by Type (2012-2017)
    2.3 EMEA DVT Screening Devices (Volume) by Application
    2.4 EMEA DVT Screening Devices (Volume and Value) by Region
        2.4.1 EMEA DVT Screening Devices Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA DVT Screening Devices Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA DVT Screening Devices Sales Price by Region (2012-2017)

3 Europe DVT Screening Devices (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe DVT Screening Devices Sales and Value (2012-2017)
        3.1.1 Europe DVT Screening Devices Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe DVT Screening Devices Revenue and Growth Rate (2012-2017)
    3.2 Europe DVT Screening Devices Sales and Market Share by Type
    3.3 Europe DVT Screening Devices Sales and Market Share by Application
    3.4 Europe DVT Screening Devices Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe DVT Screening Devices Sales Volume by Countries (2012-2017)
        3.4.2 Europe DVT Screening Devices Revenue by Countries (2012-2017)
        3.4.3 Germany DVT Screening Devices Sales and Growth Rate (2012-2017)
        3.4.4 France DVT Screening Devices Sales and Growth Rate (2012-2017)
        3.4.5 UK DVT Screening Devices Sales and Growth Rate (2012-2017)
        3.4.6 Russia DVT Screening Devices Sales and Growth Rate (2012-2017)
        3.4.7 Italy DVT Screening Devices Sales and Growth Rate (2012-2017)
        3.4.8 Benelux DVT Screening Devices Sales and Growth Rate (2012-2017)

4 Middle East DVT Screening Devices (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East DVT Screening Devices Sales and Value (2012-2017)
        4.1.1 Middle East DVT Screening Devices Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East DVT Screening Devices Revenue and Growth Rate (2012-2017)
    4.2 Middle East DVT Screening Devices Sales and Market Share by Type
    4.3 Middle East DVT Screening Devices Sales and Market Share by Application
    4.4 Middle East DVT Screening Devices Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East DVT Screening Devices Sales Volume by Countries (2012-2017)
        4.4.2 Middle East DVT Screening Devices Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia DVT Screening Devices Sales and Growth Rate (2012-2017)
        4.4.4 Israel DVT Screening Devices Sales and Growth Rate (2012-2017)
        4.4.5 UAE DVT Screening Devices Sales and Growth Rate (2012-2017)
        4.4.6 Iran DVT Screening Devices Sales and Growth Rate (2012-2017)

5 Africa DVT Screening Devices (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa DVT Screening Devices Sales and Value (2012-2017)
        5.1.1 Africa DVT Screening Devices Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa DVT Screening Devices Revenue and Growth Rate (2012-2017)
    5.2 Africa DVT Screening Devices Sales and Market Share by Type
    5.3 Africa DVT Screening Devices Sales and Market Share by Application
    5.4 Africa DVT Screening Devices Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa DVT Screening Devices Sales Volume by Countries (2012-2017)
        5.4.2 Africa DVT Screening Devices Revenue by Countries (2012-2017)
        5.4.3 South Africa DVT Screening Devices Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria DVT Screening Devices Sales and Growth Rate (2012-2017)
        5.4.5 Egypt DVT Screening Devices Sales and Growth Rate (2012-2017)
        5.4.6 Algeria DVT Screening Devices Sales and Growth Rate (2012-2017)

6 EMEA DVT Screening Devices Manufacturers/Players Profiles and Sales Data
    6.1 F. Hoffmann-La Roche Ltd.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 DVT Screening Devices Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 F. Hoffmann-La Roche Ltd. DVT Screening Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Generex Biotechnology Lorporation
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 DVT Screening Devices Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Generex Biotechnology Lorporation DVT Screening Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Laboratorios Farmaceuticos Rovi, S.A.
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 DVT Screening Devices Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Laboratorios Farmaceuticos Rovi, S.A. DVT Screening Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pharmathen Pharmaceuticals S.A.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 DVT Screening Devices Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pharmathen Pharmaceuticals S.A. DVT Screening Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Bristol-Myers Squibb Company
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 DVT Screening Devices Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Bristol-Myers Squibb Company DVT Screening Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 3SBio Inc.
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 DVT Screening Devices Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 3SBio Inc. DVT Screening Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Dupont Pharm Co
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 DVT Screening Devices Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Dupont Pharm Co DVT Screening Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Wockhardt Ltd
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 DVT Screening Devices Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Wockhardt Ltd DVT Screening Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Bayer AG
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 DVT Screening Devices Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Bayer AG DVT Screening Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Pfizer Inc.
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 DVT Screening Devices Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Pfizer Inc. DVT Screening Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 DVT Screening Devices Manufacturing Cost Analysis
    7.1 DVT Screening Devices Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of DVT Screening Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 DVT Screening Devices Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of DVT Screening Devices Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA DVT Screening Devices Market Forecast (2017-2022)
    11.1 EMEA DVT Screening Devices Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA DVT Screening Devices Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA DVT Screening Devices Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA DVT Screening Devices Price and Trend Forecast (2017-2022)
    11.2 EMEA DVT Screening Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe DVT Screening Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt DVT Screening Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa DVT Screening Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA DVT Screening Devices Sales Forecast by Type (2017-2022)
    11.7 EMEA DVT Screening Devices Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer